Press Release

View printer-friendly version << Back

vTv Therapeutics to Present at the Rodman & Renshaw Global Investment Conference

PDF Version

HIGH POINT, N.C.--(BUSINESS WIRE)--Sep. 8, 2016-- vTv Therapeutics Inc. (Nasdaq:VTVT), a clinical-stage biopharmaceutical company engaged in the discovery and development of new orally administered treatments for Alzheimer’s disease and diabetes, today announced that Company management will present a corporate overview at the Rodman & Renshaw Global Investment Conference, sponsored by H.C. Wainwright & Co., LLC. The company’s management will be presenting in the Holmes I room from 9:35 to 10:00am on September 12.

A live webcast of the presentation can be accessed on the News & Events section of the website. The webcast will be archived for 30 days following the presentation on the company website at www.vtvtherapeutics.com.

About vTv Therapeutics

vTv Therapeutics Inc. is a clinical-stage biopharmaceutical company engaged in the discovery and development of orally administered small molecule drug candidates to fill significant unmet medical needs. vTv has a pipeline of clinical drug candidates led by programs for the treatment of Alzheimer’s disease and Type 2 diabetes as well as treatment of inflammatory disorders and the prevention of muscle weakness.

Source: vTv Therapeutics Inc.

Media:
vTv Therapeutics
Nura Strong, 336-841-0300 X164
nstrong@vTvTherapeutics.com